NCT06639971View on ClinicalTrials.gov

Therapeutic Effects of Immuno-targeted Therapy Combined With or Without RT for HCC

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Hepatocellular Carcinoma (HCC)
Trial Locations (1)

200032

Zhongshan Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER

NCT06639971 - Therapeutic Effects of Immuno-targeted Therapy Combined With or Without RT for HCC | Biotech Hunter | Biotech Hunter